Literature DB >> 9406346

DNA-based immunization against hepatitis B virus.

H L Davis1, C L Brazolot Millan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9406346     DOI： 10.1007/BF00870268

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  38 in total

Review 1.  Hepatitis B virus.

Authors:  P Tiollais; M A Buendia
Journal:  Sci Am       Date:  1991-04       Impact factor: 2.142

2.  Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.

Authors:  A R Neurath; S B Kent; K Parker; A M Prince; N Strick; B Brotman; P Sproul
Journal:  Vaccine       Date:  1986-03       Impact factor: 3.641

3.  Neonatal tolerance revisited: turning on newborn T cells with dendritic cells.

Authors:  J P Ridge; E J Fuchs; P Matzinger
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

4.  Synthesis and assembly of hepatitis B virus surface antigen particles in yeast.

Authors:  P Valenzuela; A Medina; W J Rutter; G Ammerer; B D Hall
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

5.  Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle.

Authors:  H L Davis; B A Demeneix; B Quantin; J Coulombe; R G Whalen
Journal:  Hum Gene Ther       Date:  1993-12       Impact factor: 5.695

6.  Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees.

Authors:  R H Purcell; J L Gerin
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

7.  Development and chimpanzee testing of a vaccine against human hepatitis B.

Authors:  E B Buynak; R R Roehm; A A Tytell; A U Bertland; G P Lampson; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1976-04

8.  DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein.

Authors:  H L Davis; R Schirmbeck; J Reimann; R G Whalen
Journal:  Hum Gene Ther       Date:  1995-11       Impact factor: 5.695

9.  A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

Authors:  Y Itoh; E Takai; H Ohnuma; K Kitajima; F Tsuda; A Machida; S Mishiro; T Nakamura; Y Miyakawa; M Mayumi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg.

Authors:  M Mancini; M Hadchouel; P Tiollais; C Pourcel; M L Michel
Journal:  J Med Virol       Date:  1993-01       Impact factor: 2.327
View more
  3 in total

1.  Intralymphatic immunization enhances DNA vaccination.

Authors:  K J Maloy; I Erdmann; V Basch; S Sierro; T A Kramps; R M Zinkernagel; S Oehen; T M Kündig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

2.  Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2/S induced by gene immunization.

Authors:  Li-Xin Wang; Wei Xu; Qing-Dong Guan; Yi-Wei Chu; Ying Wang; Si-Dong Xiong
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

3.  Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.

Authors:  T Arichi; T Saito; M E Major; I M Belyakov; M Shirai; V H Engelhard; S M Feinstone; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.